 INDIANAPOLIS and UTRECHT, The Netherlands, Jan. 19, 2021 PRNewswire -- Loxo Oncology at Lilly, a research and development group of Eli Lilly and Company NYSE: LLY, and Merus N.V. NASDAQ: MRUS, a clinical-stage oncology company developing multi-specific antibodies, today announced a... 